| Year |
Citation |
Score |
| 2016 |
Cidado J, Wong HY, Rosen DM, Cimino-Mathews A, Garay JP, Fessler AG, Rasheed ZA, Hicks J, Cochran RL, Croessmann S, Zabransky DJ, Mohseni M, Beaver JA, Chu D, Cravero K, et al. Ki-67 is required for maintenance of cancer stem cells but not cell proliferation. Oncotarget. PMID 26823390 DOI: 10.18632/Oncotarget.7057 |
0.804 |
|
| 2015 |
Croessmann S, Wong HY, Zabransky DJ, Chu D, Mendonca J, Sharma A, Mohseni M, Rosen DM, Scharpf RB, Cidado J, Cochran RL, Parsons HA, Dalton WB, Erlanger B, Button B, et al. NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability. Proceedings of the National Academy of Sciences of the United States of America. 112: 11583-8. PMID 26324937 DOI: 10.1073/Pnas.1503683112 |
0.777 |
|
| 2015 |
Blair BG, Wu X, Zahari MS, Mohseni M, Cidado J, Wong HY, Beaver JA, Cochran RL, Zabransky DJ, Croessmann S, Chu D, Toro PV, Cravero K, Pandey A, Park BH. A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations. Proteomics. 15: 318-26. PMID 25367220 DOI: 10.1002/Pmic.201400342 |
0.821 |
|
| 2014 |
Mohseni M, Cidado J, Croessmann S, Cravero K, Cimino-Mathews A, Wong HY, Scharpf R, Zabransky DJ, Abukhdeir AM, Garay JP, Wang GM, Beaver JA, Cochran RL, Blair BG, Rosen DM, et al. MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers. Proceedings of the National Academy of Sciences of the United States of America. 111: 17606-11. PMID 25422431 DOI: 10.1073/Pnas.1408650111 |
0.766 |
|
| 2014 |
Wu X, Renuse S, Sahasrabuddhe NA, Zahari MS, Chaerkady R, Kim MS, Nirujogi RS, Mohseni M, Kumar P, Raju R, Zhong J, Yang J, Neiswinger J, Jeong JS, Newman R, et al. Activation of diverse signalling pathways by oncogenic PIK3CA mutations. Nature Communications. 5: 4961. PMID 25247763 DOI: 10.1038/Ncomms5961 |
0.755 |
|
| 2013 |
Wang GM, Wong HY, Konishi H, Blair BG, Abukhdeir AM, Gustin JP, Rosen DM, Denmeade SR, Rasheed Z, Matsui W, Garay JP, Mohseni M, Higgins MJ, Cidado J, Jelovac D, et al. Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation. Cancer Research. 73: 3248-61. PMID 23580570 DOI: 10.1158/0008-5472.Can-12-1578 |
0.759 |
|
| 2012 |
Garay JP, Karakas B, Abukhdeir AM, Cosgrove DP, Gustin JP, Higgins MJ, Konishi H, Konishi Y, Lauring J, Mohseni M, Wang GM, Jelovac D, Weeraratna A, Sherman Baust CA, Morin PJ, et al. The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation. Breast Cancer Research : Bcr. 14: R27. PMID 22321971 DOI: 10.1186/Bcr3112 |
0.789 |
|
| 2012 |
Wu X, Sahasrabuddhe NA, Renuse S, Zahari S, Chaerkady R, Mohseni M, Yang J, Kim M, Zhong J, Qian J, Zhu H, Vogelstein B, Park BH, Pandey A. Abstract 985: Dissecting PI3K-AKT pathway by phosphoproteomic profiling of PIK3CA knock-in mutants Cancer Research. 72: 985-985. DOI: 10.1158/1538-7445.Am2012-985 |
0.79 |
|
| 2011 |
Konishi H, Mohseni M, Tamaki A, Garay JP, Croessmann S, Karnan S, Ota A, Wong HY, Konishi Y, Karakas B, Tahir K, Abukhdeir AM, Gustin JP, Cidado J, Wang GM, et al. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 17773-8. PMID 21987798 DOI: 10.1073/Pnas.1110969108 |
0.799 |
|
| 2011 |
Higgins MJ, Beaver JA, Wong HY, Gustin JP, Lauring JD, Garay JP, Konishi H, Mohseni M, Wang GM, Cidado J, Jelovac D, Cosgrove DP, Tamaki A, Abukhdeir AM, Park BH. PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells. Cancer Biology & Therapy. 11: 358-67. PMID 21124076 DOI: 10.4161/Cbt.11.3.14227 |
0.808 |
|
| 2010 |
Mohseni M, Park BH. PIK3CA and KRAS mutations predict for response to everolimus therapy: Now that's RAD001 Journal of Clinical Investigation. 120: 2655-2658. PMID 20664174 DOI: 10.1172/Jci44026 |
0.674 |
|
| 2010 |
Weiss MB, Vitolo MI, Mohseni M, Rosen DM, Denmeade SR, Park BH, Weber DJ, Bachman KE. Deletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic response. Oncogene. 29: 4715-24. PMID 20562907 DOI: 10.1038/Onc.2010.220 |
0.665 |
|
| 2010 |
Lauring J, Cosgrove DP, Fontana S, Gustin JP, Konishi H, Abukhdeir AM, Garay JP, Mohseni M, Wang GM, Higgins MJ, Gorkin D, Reis M, Vogelstein B, Polyak K, Cowherd M, et al. Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations Oncogene. 29: 2337-2345. PMID 20101210 DOI: 10.1038/Onc.2009.516 |
0.823 |
|
| 2010 |
Karnan S, Mohseni M, Konishi Y, Tamaki A, Hosokawa Y, Park BH, Konishi H. Controversial BRCA1 allelotypes in commonly used breast cancer cell lines. Breast Cancer Research and Treatment. 119: 249-51. PMID 19585236 DOI: 10.1007/S10549-009-0465-3 |
0.681 |
|
| 2009 |
Gustin JP, Karakas B, Weiss MB, Abukhdeir AM, Lauring J, Garay JP, Cosgrove D, Tamaki A, Konishi H, Konishi Y, Mohseni M, Wang G, Rosen DM, Denmeade SR, Higgins MJ, et al. Knockin of mutant PIK3CA activates multiple oncogenic pathways. Proceedings of the National Academy of Sciences of the United States of America. 106: 2835-40. PMID 19196980 DOI: 10.1073/Pnas.0813351106 |
0.833 |
|
| Show low-probability matches. |